We are live on ! Find out more
VanEck Associates

VanEck Associates Portfolio holdings

AUM $133B
1-Year Est. Return 72.99%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$133B
AUM Growth
+$12.2B
Cap. Flow
+$7.34B
Cap. Flow %
5.51%
Top 10 Hldgs %
31.59%
Holding
1,470
New
67
Increased
946
Reduced
372
Closed
66

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$1.09B
2
AEM icon
Agnico Eagle Mines
AEM
+$830M
3
AVGO icon
Broadcom
AVGO
+$763M
4
NEM icon
Newmont
NEM
+$717M
5
TSM icon
TSMC
TSM
+$618M

Sector Composition

Rank Sector Weight
1 Technology 41.47%
2 Materials 28.65%
3 Industrials 6.66%
4 Energy 5.06%
5 Healthcare 4.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NG icon
226
NovaGold Resources
NG
$2.72B
$68.7M 0.05%
7,655,374
+70,165
+0.9% +$722K
MCK icon
227
McKesson
MCK
$95.3B
$68.6M 0.05%
79,241
-3,603
-4% -$3.22M
KBR icon
228
KBR
KBR
$4.52B
$68.3M 0.05%
1,852,601
-24,766
-1% -$1.02M
AMGN icon
229
Amgen
AMGN
$198B
$67.9M 0.05%
193,115
-624,719
-76% -$223M
XYZ
230
Block Inc
XYZ
$46.1B
$67.4M 0.05%
1,119,608
-23,165
-2% -$1.41M
VSAT icon
231
Viasat
VSAT
$10.2B
$67.1M 0.05%
1,465,279
+438,915
+43% +$19.7M
VALE icon
232
Vale
VALE
$63.2B
$66.9M 0.05%
4,207,323
+807,053
+24% +$12.6M
NTES icon
233
NetEase
NTES
$77.6B
$65.7M 0.05%
586,902
-47,611
-8% -$5.91M
VRTX icon
234
Vertex Pharmaceuticals
VRTX
$120B
$65.2M 0.05%
146,116
-3,335
-2% -$1.56M
EINC icon
235
VanEck Energy Income ETF
EINC
$101M
$65M 0.05%
551,666
+291,398
+112% +$31.6M
GSAT icon
236
Globalstar
GSAT
$10.3B
$64.7M 0.05%
974,287
+389,686
+67% +$23.8M
SLI
237
Standard Lithium
SLI
$561M
$64M 0.05%
18,782,350
+3,242,915
+21% +$14.5M
VLO icon
238
Valero Energy
VLO
$92.3B
$63.2M 0.05%
255,978
-82,472
-24% -$17M
MFC icon
239
Manulife Financial
MFC
$71.5B
$63M 0.05%
1,830,796
+501,160
+38% +$18M
SNY icon
240
Sanofi
SNY
$105B
$62.5M 0.05%
1,297,714
+52,717
+4% +$2.46M
WHD icon
241
Cactus
WHD
$3.89B
$62.4M 0.05%
1,317,631
+389,090
+42% +$20.4M
GLDM icon
242
SPDR Gold MiniShares Trust
GLDM
$28B
$62.2M 0.05%
671,036
MRCY icon
243
Mercury Systems
MRCY
$5.94B
$62.1M 0.05%
851,145
+125,758
+17% +$11M
NNE
244
Nano Nuclear Energy
NNE
$903M
$61.6M 0.05%
3,009,825
-231,525
-7% -$6.32M
NLY icon
245
Annaly Capital Management
NLY
$16.4B
$61.1M 0.05%
2,889,651
+182,773
+7% +$4.16M
FLY
246
Firefly Aerospace
FLY
$3.32B
$60.4M 0.05%
+2,120,531
New +$51.6M
LASR icon
247
nLIGHT
LASR
$4.09B
$59.8M 0.04%
+1,048,325
New +$56.8M
NVO
248
Novo Nordisk
NVO
$213B
$59.6M 0.04%
1,621,481
-23,668
-1% -$1.12M
GSK icon
249
GSK
GSK
$102B
$58.9M 0.04%
1,066,648
-127,719
-11% -$6.92M
ALLE icon
250
Allegion
ALLE
$12B
$58.8M 0.04%
404,905
-1,092
-0.3% -$174K

Similar funds

VanEck Associates's Q1 2026 Portfolio in Review

As of Q1 2026, VanEck Associates held 1,470 positions worth $133B, up 10% from $121B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

VanEck Associates deployed $7.34B of net new capital in Q1 2026, opening 67 new positions and adding to 946 existing holdings. Its largest new stake was United States Antimony: 10,369,695 shares worth $90.5M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, down from 42% a quarter earlier, followed by Materials and Industrials.

On the sell side, the largest reduction was Pan American Silver, an estimated $1.04B trimmed.

  • VanEck Associates's largest Q1 2026 buy was United States Antimony: 10,369,695 shares worth $90.5M.
  • VanEck Associates added most to NVIDIA in Q1 2026, an estimated $1.09B increase.
  • VanEck Associates's biggest Q1 2026 reduction was Pan American Silver, cutting an estimated $1.04B.
  • VanEck Associates fully exited Ur-Energy in Q1 2026, selling an estimated $28.4M.
  • VanEck Associates's ten largest holdings make up 32% of its $133B portfolio in Q1 2026.
  • VanEck Associates opened 67 new positions and closed 66 in Q1 2026.
  • VanEck Associates's portfolio value rose 10% quarter-over-quarter to $133B.

Based on VanEck Associates's 13F filing for Q1 2026, filed 15 May 2026.